Oncologic Samples
The category Oncologic Samples encompasses diverse human biospecimens of benign, in situ and malignant neoplasm samples like Leukaemia, Lymphoma, Breast, Brain, Eye, Lung, Pancreatic, Prostate, Skin or Uterus Cancer. Procurement takes place from consented donors under strict ethical standards. You can use our filter functions to perform complex searches according to laboratory parameters, disease in clear name or ICD-10 code, patient annotation, such as age, gender, BMI and ethnicity. If you do not find the samples you are looking for, please contact us.
26,284 Products
Human Serum - Complement C3 - D47.5
- Donor:
- Gender: Male Age: 30
- Diagnosed disease:
- D47.5 - Chronic eosinophilic leukaemia [hypereosinophilic syndrome]
- Parameter:
- 25-Hydroxy-Vitamin D3 (Calcidiol) Anti-Bactericidal / Permeability Increasing Protein (BPI) Anti-Mutated citrullinated Vimentin (MCV) Anti-Myeloperoxidase (MPO) Anti-Proteinase 3 (PR3) Anti-cyclic citrullinated Peptide (CCP) / anti-citrullinated Protein Antibodies (ACPA) Anti-double-stranded DNA (dsDNA) Beta-CrossLaps (b-CTX) Bone alkaline phosphatase (BAP) Capsule-reactive protein (CRP) ...
Donor:
- Gender:
- Male
- Age:
- 30 Years
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Chronic eosinophilic leukaemia [hypereosinophilic syndrome] [D47.5]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| 25-Hydroxy-Vitamin D3 (Calcidiol) |
Qual: negative
Quant: 44.60 ng/mL
Source: this donation
|
30.00 - 100 ng/mL
|
Method: CLIA (Chemiluminescence Immuno Assay) System: ISYS IDS |
| Anti-Bactericidal / Permeability Increasing Protein (BPI) |
Qual: negative
Quant: 5.70 U/mL
Source: this donation
|
< 10.00 U/mL
|
Method: ELISA (Enzyme Linked Immunosorbent Assay) System: BEP2000 Siemens |
| Anti-Mutated citrullinated Vimentin (MCV) |
Qual: negative
Quant: 9.40 U/mL
Source: this donation
|
< 20.00 U/mL
|
Method: ELISA (Enzyme Linked Immunosorbent Assay) System: BEP2000 Siemens |
| Anti-Myeloperoxidase (MPO) |
Qual: negative
Quant: 0.80 U/mL
Source: this donation
|
< 5.00 U/mL
|
Method: ELISA (Enzyme Linked Immunosorbent Assay) System: BEP2000 Siemens |
| Anti-Proteinase 3 (PR3) |
Qual: negative
Quant: 0.70 U/mL
Source: this donation
|
< 10.00 U/mL
|
Method: ELISA (Enzyme Linked Immunosorbent Assay) System: BEP2000 Siemens |
| Anti-cyclic citrullinated Peptide (CCP) / anti-citrullinated Protein Antibodies (ACPA) |
Qual: negative
Quant: 3.02 RU/mL
Source: this donation
|
< 5.00 RU/mL
|
Method: ELISA (Enzyme Linked Immunosorbent Assay) System: Analyzer1 EUROIMMUN AG |
| Anti-double-stranded DNA (dsDNA) |
Qual: negative
Quant: 5.40 IU/mL
Source: this donation
|
< 20.00 IU/mL
|
Method: ELISA (Enzyme Linked Immunosorbent Assay) System: BEP2000 Siemens |
| Beta-CrossLaps (b-CTX) |
Qual: negative
Quant: 0.259 ng/mL
Source: this donation
|
0.115 - 0.748 ng/mL
Remarks: sex and age dependent |
Method: CLIA (Chemiluminescence Immuno Assay) System: ISYS IDS |
| Bone alkaline phosphatase (BAP) |
Qual: negative
Quant: 16.40 µg/L
Source: this donation
|
5.70 - 32.90 µg/L
Remarks: sex and age dependent |
Method: EIA (Enzyme Immuno Assay) System: ISYS IDS |
| Capsule-reactive protein (CRP) |
Qual: negative
Quant: 1.11 mg/L
Source: this donation
|
0.00 - 3.00 mg/L
|
Method: Nephelometry System: BN ProSpec Siemens |
| Complement C3 |
Qual: positive
Quant: 0.89 g/L
Source: this donation
|
0.90 - 1.80 g/L
|
Method: Nephelometry System: BN ProSpec Siemens |
| Complement C4 |
Qual: negative
Quant: 0.16 g/L
Source: this donation
|
0.10 - 0.40 g/L
|
Method: Nephelometry System: BN ProSpec Siemens |
| Osteocalcin |
Qual: negative
Quant: 17.20 ng/mL
Source: this donation
|
10.40 - 45.60 ng/mL
|
Method: CLIA (Chemiluminescence Immuno Assay) System: ISYS IDS |
| Parathyroid hormone (PTH) |
Qual: negative
Quant: 18.30 pg/mL
Source: this donation
|
11.50 - 78.40 pg/mL
|
Method: CLIA (Chemiluminescence Immuno Assay) System: ISYS IDS |
| Rheumatoid Factor (RF) IgA |
Qual: negative
Quant: < 1.00 U/mL
Source: this donation
|
< 20.00 U/mL
|
Method: ELISA (Enzyme Linked Immunosorbent Assay) System: BEP2000 Siemens |
| Rheumatoid Factor (RF) IgG |
Qual: negative
Quant: 7.30 U/mL
Source: this donation
|
< 20.00 U/mL
|
Method: ELISA (Enzyme Linked Immunosorbent Assay) System: BEP2000 Siemens |
| Rheumatoid Factor (RF) IgM |
Qual: negative
Quant: < 1.00 IU/mL
Source: this donation
|
< 20.00 IU/mL
|
Method: ELISA (Enzyme Linked Immunosorbent Assay) System: BEP2000 Siemens |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH183931
0.5 mL (€56.25)
Human Li-heparin plasma - Erythrocyte sedimentation rate (ESR) ... - C43.9
- Donor:
- Gender: Female Age: 48 Ethnic group: European/Caucasian
- Diagnosed disease:
- C43.9 - Malignant melanoma of skin, unspecified
- Medication:
- Novaminsulfon
- Parameter:
- Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Total Rheumatoid Factor (tRF)
Donor:
- Gender:
- Female
- Age:
- 48 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 28 kg/m²
- Weight:
- 72 kg
- Height:
- 159 cm
Sample:
- Matrix:
- Li-heparin plasma
- Condition:
- perfect
- Freeze-Thaw-Cycle:
- 1
Diseases:
- Malignant melanoma of skin, unspecified [C43.9]
Medication:
- Novaminsulfon (Dosages: 500mg, as needed)
- Xeljanz (Dosages: 10mg/day, active agent: tofacitinib)
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Capsule-reactive protein (CRP) |
Qual: negative
Quant: 0.6 mg/L
Source: this donation
|
< 5.00 mg/L
|
Method: not specified System: Modular Roche |
| Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) |
Qual:
Quant: 18.00 mm/1h
Source: this donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Total Rheumatoid Factor (tRF) |
Qual: negative
Quant: < 10.00 IU/mL
Source: this donation
|
< 14.00 IU/mL
|
Method: not specified System: Modular Roche |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH234438
1 mL (€37.50)
Human K3EDTA plasma - Erythrocyte sedimentation rate (ESR) ... - C43.9
- Donor:
- Gender: Female Age: 48 Ethnic group: European/Caucasian
- Diagnosed disease:
- C43.9 - Malignant melanoma of skin, unspecified
- Medication:
- Novaminsulfon
- Parameter:
- Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Total Rheumatoid Factor (tRF)
Donor:
- Gender:
- Female
- Age:
- 48 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 28 kg/m²
- Weight:
- 72 kg
- Height:
- 159 cm
Sample:
- Matrix:
- K3EDTA plasma
- Condition:
- perfect
- Freeze-Thaw-Cycle:
- 1
Diseases:
- Malignant melanoma of skin, unspecified [C43.9]
Medication:
- Novaminsulfon (Dosages: 500mg, as needed)
- Xeljanz (Dosages: 10mg/day, active agent: tofacitinib)
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Capsule-reactive protein (CRP) |
Qual: negative
Quant: 0.6 mg/L
Source: this donation
|
< 5.00 mg/L
|
Method: not specified System: Modular Roche |
| Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) |
Qual:
Quant: 18.00 mm/1h
Source: this donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Total Rheumatoid Factor (tRF) |
Qual: negative
Quant: < 10.00 IU/mL
Source: this donation
|
< 14.00 IU/mL
|
Method: not specified System: Modular Roche |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH234437
1 mL (€37.50)
Human Serum - Erythrocyte sedimentation rate (ESR) ... - C43.9
- Donor:
- Gender: Female Age: 48 Ethnic group: European/Caucasian
- Diagnosed disease:
- C43.9 - Malignant melanoma of skin, unspecified
- Medication:
- Novaminsulfon
- Parameter:
- Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Total Rheumatoid Factor (tRF)
Donor:
- Gender:
- Female
- Age:
- 48 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 28 kg/m²
- Weight:
- 72 kg
- Height:
- 159 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Freeze-Thaw-Cycle:
- 1
Diseases:
- Malignant melanoma of skin, unspecified [C43.9]
Medication:
- Novaminsulfon (Dosages: 500mg, as needed)
- Xeljanz (Dosages: 10mg/day, active agent: tofacitinib)
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Capsule-reactive protein (CRP) |
Qual: negative
Quant: 0.6 mg/L
Source: this donation
|
< 5.00 mg/L
|
Method: not specified System: Modular Roche |
| Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) |
Qual:
Quant: 18.00 mm/1h
Source: this donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Total Rheumatoid Factor (tRF) |
Qual: negative
Quant: < 10.00 IU/mL
Source: this donation
|
< 14.00 IU/mL
|
Method: not specified System: Modular Roche |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH234436
1 mL (€37.50)
Human K3EDTA plasma - Erythrocyte sedimentation rate (ESR) ... - C50.9
- Donor:
- Gender: Female Age: 76 Ethnic group: European/Caucasian
- Diagnosed disease:
- C50.9 - Malignant neoplasm of breast, unspecified
- Medication:
- Aclasta
- Parameter:
- Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Total Rheumatoid Factor (tRF)
Donor:
- Gender:
- Female
- Age:
- 76 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 23 kg/m²
- Weight:
- 67 kg
- Height:
- 170 cm
Sample:
- Matrix:
- K3EDTA plasma
- Condition:
- perfect
- Freeze-Thaw-Cycle:
- 1
Diseases:
- Malignant neoplasm of breast, unspecified [C50.9]
Medication:
- Aclasta (Dosages: 5mg/6 months, active agent: zoledronic acid)
- leflunomide (Dosages: 10mg/day)
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Capsule-reactive protein (CRP) |
Qual: negative
Quant: 3.85 mg/L
Source: this donation
|
< 5.00 mg/L
|
Method: not specified System: Modular Roche |
| Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) |
Qual:
Quant: 69.00 mm/1h
Source: this donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Total Rheumatoid Factor (tRF) |
Qual: negative
Quant: < 10.00 IU/mL
Source: this donation
|
< 14.00 IU/mL
|
Method: not specified System: Modular Roche |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH241243
1 mL (€37.50)
Human Li-heparin plasma - Erythrocyte sedimentation rate (ESR) ... - C50.9
- Donor:
- Gender: Female Age: 76 Ethnic group: European/Caucasian
- Diagnosed disease:
- C50.9 - Malignant neoplasm of breast, unspecified
- Medication:
- Aclasta
- Parameter:
- Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Total Rheumatoid Factor (tRF)
Donor:
- Gender:
- Female
- Age:
- 76 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 23 kg/m²
- Weight:
- 67 kg
- Height:
- 170 cm
Sample:
- Matrix:
- Li-heparin plasma
- Condition:
- perfect
- Freeze-Thaw-Cycle:
- 1
Diseases:
- Malignant neoplasm of breast, unspecified [C50.9]
Medication:
- Aclasta (Dosages: 5mg/6 months, active agent: zoledronic acid)
- leflunomide (Dosages: 10mg/day)
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Capsule-reactive protein (CRP) |
Qual: negative
Quant: 3.85 mg/L
Source: this donation
|
< 5.00 mg/L
|
Method: not specified System: Modular Roche |
| Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) |
Qual:
Quant: 69.00 mm/1h
Source: this donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Total Rheumatoid Factor (tRF) |
Qual: negative
Quant: < 10.00 IU/mL
Source: this donation
|
< 14.00 IU/mL
|
Method: not specified System: Modular Roche |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH241244
1 mL (€37.50)
Human K3EDTA plasma - Capsule-reactive protein (CRP), Eryth... - C82.9
- Donor:
- Gender: Female Age: 35 Ethnic group: European/Caucasian
- Diagnosed disease:
- C82.9 - Follicular lymphoma, unspecified
- Medication:
- Metex
- Parameter:
- Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Total Rheumatoid Factor (tRF)
Donor:
- Gender:
- Female
- Age:
- 35 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 19 kg/m²
- Weight:
- 58 kg
- Height:
- 174 cm
Sample:
- Matrix:
- K3EDTA plasma
- Condition:
- perfect
- Freeze-Thaw-Cycle:
- 1
Diseases:
- Follicular lymphoma, unspecified [C82.9]
Medication:
- Metex (Dosages: 15mg/week)
- folic acid (Dosages: 5mg/week)
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Capsule-reactive protein (CRP) |
Qual: positive
Quant: 11.10 mg/L
Source: this donation
|
< 5.00 mg/L
|
Method: not specified System: Modular Roche |
| Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) |
Qual:
Quant: 21.00 mm/1h
Source: this donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Total Rheumatoid Factor (tRF) |
Qual: negative
Quant: < 10.00 IU/mL
Source: this donation
|
< 14.00 IU/mL
|
Method: not specified System: Modular Roche |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH252424
1 mL (€37.50)
Human Li-heparin plasma - Capsule-reactive protein (CRP), Eryth... - C82.9
- Donor:
- Gender: Female Age: 35 Ethnic group: European/Caucasian
- Diagnosed disease:
- C82.9 - Follicular lymphoma, unspecified
- Medication:
- Metex
- Parameter:
- Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Total Rheumatoid Factor (tRF)
Donor:
- Gender:
- Female
- Age:
- 35 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 19 kg/m²
- Weight:
- 58 kg
- Height:
- 174 cm
Sample:
- Matrix:
- Li-heparin plasma
- Condition:
- perfect
- Freeze-Thaw-Cycle:
- 1
Diseases:
- Follicular lymphoma, unspecified [C82.9]
Medication:
- Metex (Dosages: 15mg/week)
- folic acid (Dosages: 5mg/week)
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Capsule-reactive protein (CRP) |
Qual: positive
Quant: 11.10 mg/L
Source: this donation
|
< 5.00 mg/L
|
Method: not specified System: Modular Roche |
| Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) |
Qual:
Quant: 21.00 mm/1h
Source: this donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Total Rheumatoid Factor (tRF) |
Qual: negative
Quant: < 10.00 IU/mL
Source: this donation
|
< 14.00 IU/mL
|
Method: not specified System: Modular Roche |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH252425
1 mL (€37.50)
Human Serum - Capsule-reactive protein (CRP), Eryth... - C82.9
- Donor:
- Gender: Female Age: 35 Ethnic group: European/Caucasian
- Diagnosed disease:
- C82.9 - Follicular lymphoma, unspecified
- Medication:
- Metex
- Parameter:
- Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Total Rheumatoid Factor (tRF)
Donor:
- Gender:
- Female
- Age:
- 35 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 19 kg/m²
- Weight:
- 58 kg
- Height:
- 174 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Freeze-Thaw-Cycle:
- 1
Diseases:
- Follicular lymphoma, unspecified [C82.9]
Medication:
- Metex (Dosages: 15mg/week)
- folic acid (Dosages: 5mg/week)
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Capsule-reactive protein (CRP) |
Qual: positive
Quant: 11.10 mg/L
Source: this donation
|
< 5.00 mg/L
|
Method: not specified System: Modular Roche |
| Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) |
Qual:
Quant: 21.00 mm/1h
Source: this donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Total Rheumatoid Factor (tRF) |
Qual: negative
Quant: < 10.00 IU/mL
Source: this donation
|
< 14.00 IU/mL
|
Method: not specified System: Modular Roche |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH252423
1 mL (€37.50)
Human Serum - Capsule-reactive protein (CRP), Eryth... - D35.2
- Donor:
- Gender: Male Age: 62
- Diagnosed disease:
- D35.2 - Benign neoplasm of pituitary gland
- Medication:
- Enbrel
- Parameter:
- Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Rheumatoid Factor (RF)
Donor:
- Gender:
- Male
- Age:
- 62 Years
- BMI:
- 27 kg/m²
- Weight:
- 88 kg
- Height:
- 182 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Anamneses:
- DAS28-Score 2,02 (27.08.2018)
- Swollen Joint Count (SJC) 0 (27.08.2018)
- Tender Joint Count (TJC) 0 (27.08.2018)
- Visual analogue scale (VAS) 30 mm (27.08.2018)
- DAS28-Score 2,02 (27.08.2018)
- Swollen Joint Count (SJC) 0 (27.08.2018)
- Tender Joint Count (TJC) 0 (27.08.2018)
- Visual analogue scale (VAS) 30 mm (27.08.2018)
- DAS28-Score 2,02 (27.08.2018)
- Swollen Joint Count (SJC) 0 (27.08.2018)
- Tender Joint Count (TJC) 0 (27.08.2018)
- Visual analogue scale (VAS) 30 mm (27.08.2018)
- DAS28-Score 2,02 (27.08.2018)
- Swollen Joint Count (SJC) 0 (27.08.2018)
- Tender Joint Count (TJC) 0 (27.08.2018)
- Visual analogue scale (VAS) 30 mm (27.08.2018)
Diseases:
- Benign neoplasm of pituitary gland [D35.2]
Medication:
- Enbrel (Dosages: 50mg/week, active agent: etanercept)
- no other chronic medication
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Capsule-reactive protein (CRP) |
Qual:
Quant: 1.11 mg/L
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) |
Qual:
Quant: 8.00 mm/1h
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Rheumatoid Factor (RF) |
Qual:
Quant: 9.00 IU/mL
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH279112
1 mL (€37.50)
Human Serum - Bone alkaline phosphatase (BAP), Caps... - C81.1
- Donor:
- Gender: Female Age: 80
- Diagnosed disease:
- C81.1 - Nodular sclerosis (classical) Hodgkin lymphoma
- Parameter:
- 25-Hydroxy-Vitamin D3 (Calcidiol) Anti-Mutated citrullinated Vimentin (MCV) Anti-Myeloperoxidase (MPO) Anti-Proteinase 3 (PR3) Anti-cyclic citrullinated Peptide (CCP) / anti-citrullinated Protein Antibodies (ACPA) Beta-CrossLaps (b-CTX) Bone alkaline phosphatase (BAP) Capsule-reactive protein (CRP) Complement C3 Complement C4 ...
Donor:
- Gender:
- Female
- Age:
- 80 Years
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Nodular sclerosis (classical) Hodgkin lymphoma [C81.1]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| 25-Hydroxy-Vitamin D3 (Calcidiol) |
Qual: negative
Quant: 44.80 ng/mL
Source: this donation
|
30.00 - 100 ng/mL
|
Method: CLIA (Chemiluminescence Immuno Assay) System: ISYS IDS |
| Anti-Mutated citrullinated Vimentin (MCV) |
Qual: negative
Quant: 5.80 U/mL
Source: this donation
|
< 20.00 U/mL
|
Method: ELISA (Enzyme Linked Immunosorbent Assay) System: BEP2000 Siemens |
| Anti-Myeloperoxidase (MPO) |
Qual: negative
Quant: 1.70 U/mL
Source: this donation
|
< 5.00 U/mL
|
Method: ELISA (Enzyme Linked Immunosorbent Assay) System: BEP2000 Siemens |
| Anti-Proteinase 3 (PR3) |
Qual: negative
Quant: 2.10 U/mL
Source: this donation
|
< 10.00 U/mL
|
Method: ELISA (Enzyme Linked Immunosorbent Assay) System: BEP2000 Siemens |
| Anti-cyclic citrullinated Peptide (CCP) / anti-citrullinated Protein Antibodies (ACPA) |
Qual: negative
Quant: 1.00 RU/mL
Source: this donation
|
< 5.00 RU/mL
|
Method: ELISA (Enzyme Linked Immunosorbent Assay) System: Analyzer1 EUROIMMUN AG |
| Beta-CrossLaps (b-CTX) |
Qual: negative
Quant: 0.154 ng/mL
Source: this donation
|
0.142 - 1.351 ng/mL
Remarks: sex and age dependent |
Method: CLIA (Chemiluminescence Immuno Assay) System: ISYS IDS |
| Bone alkaline phosphatase (BAP) |
Qual: positive
Quant: 43.70 µg/L
Source: this donation
|
5.50 - 27.10 µg/L
Remarks: sex and age dependent |
Method: EIA (Enzyme Immuno Assay) System: ISYS IDS |
| Capsule-reactive protein (CRP) |
Qual: positive
Quant: 4.49 mg/L
Source: this donation
|
0.00 - 3.00 mg/L
|
Method: Nephelometry System: BN ProSpec Siemens |
| Complement C3 |
Qual: negative
Quant: 1.30 g/L
Source: this donation
|
0.90 - 1.80 g/L
|
Method: Nephelometry System: BN ProSpec Siemens |
| Complement C4 |
Qual: negative
Quant: 0.32 g/L
Source: this donation
|
0.10 - 0.40 g/L
|
Method: Nephelometry System: BN ProSpec Siemens |
| Osteocalcin |
Qual: negative
Quant: 12.20 ng/mL
Source: this donation
|
10.40 - 45.60 ng/mL
|
Method: CLIA (Chemiluminescence Immuno Assay) System: ISYS IDS |
| Parathyroid hormone (PTH) |
Qual: negative
Quant: 32.50 pg/mL
Source: this donation
|
11.50 - 78.40 pg/mL
|
Method: CLIA (Chemiluminescence Immuno Assay) System: ISYS IDS |
| Rheumatoid Factor (RF) IgA |
Qual: negative
Quant: < 1.00 U/mL
Source: this donation
|
< 20.00 U/mL
|
Method: ELISA (Enzyme Linked Immunosorbent Assay) System: BEP2000 Siemens |
| Rheumatoid Factor (RF) IgG |
Qual: negative
Quant: 11.10 U/mL
Source: this donation
|
< 20.00 U/mL
|
Method: ELISA (Enzyme Linked Immunosorbent Assay) System: BEP2000 Siemens |
| Rheumatoid Factor (RF) IgM |
Qual: negative
Quant: 6.70 IU/mL
Source: this donation
|
< 20.00 IU/mL
|
Method: ELISA (Enzyme Linked Immunosorbent Assay) System: BEP2000 Siemens |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH286254
0.7 mL (€78.75)
Human Li-heparin plasma - Anti-cyclic citrullinated Peptide (CC... - D15.1
- Donor:
- Gender: Female Age: 48
- Diagnosed disease:
- D15.1 - Benign neoplasm of heart
- Parameter:
- Anti-cyclic citrullinated Peptide (CCP) / anti-citrullinated Protein Antibodies (ACPA) Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Hematokrit Rheumatoid Factor (RF)
Donor:
- Gender:
- Female
- Age:
- 48 Years
Sample:
- Matrix:
- Li-heparin plasma
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Anamneses:
- in remission yes (2015-08)
- in remission yes (2015-08)
- in remission yes (2015-08)
- in remission yes (2015-08)
- in remission yes (2015-08)
Diseases:
- Benign neoplasm of heart [D15.1]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-cyclic citrullinated Peptide (CCP) / anti-citrullinated Protein Antibodies (ACPA) |
Qual:
Quant: 15 IU/mL
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Capsule-reactive protein (CRP) |
Qual:
Quant: 4.9 mg/L
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) |
Qual:
Quant: 47 mm/1h
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Hematokrit |
Qual:
Quant: 0.43 %
Source: this donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Rheumatoid Factor (RF) |
Qual: negative
Quant: < 14.00 IU/mL
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH251813
1 mL (€37.50)
Human Serum - Anti-cyclic citrullinated Peptide (CC... - D15.1
- Donor:
- Gender: Female Age: 48
- Diagnosed disease:
- D15.1 - Benign neoplasm of heart
- Parameter:
- Anti-cyclic citrullinated Peptide (CCP) / anti-citrullinated Protein Antibodies (ACPA) Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Hematokrit Rheumatoid Factor (RF)
Donor:
- Gender:
- Female
- Age:
- 48 Years
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Anamneses:
- in remission yes (2015-08)
- in remission yes (2015-08)
- in remission yes (2015-08)
- in remission yes (2015-08)
- in remission yes (2015-08)
Diseases:
- Benign neoplasm of heart [D15.1]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-cyclic citrullinated Peptide (CCP) / anti-citrullinated Protein Antibodies (ACPA) |
Qual:
Quant: 15 IU/mL
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Capsule-reactive protein (CRP) |
Qual:
Quant: 4.9 mg/L
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) |
Qual:
Quant: 47 mm/1h
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Hematokrit |
Qual:
Quant: 0.43 %
Source: this donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Rheumatoid Factor (RF) |
Qual: negative
Quant: < 14.00 IU/mL
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH251814
1 mL (€37.50)
Human Serum - Capsule-reactive protein (CRP) - C24.1
- Donor:
- Gender: Female Age: 48
- Diagnosed disease:
- C24.1 - Malignant neoplasm of ampulla of Vater
- Parameter:
- Capsule-reactive protein (CRP) Procalcitonin (PCT)
Donor:
- Gender:
- Female
- Age:
- 48 Years
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Anamneses:
- admission to the intensive care unit (ICU) yes (information given at the time donation)
- specialty of the intensive care unit (ICU) general surgery (information given at the time donation)
- admission to the intensive care unit (ICU) yes (information given at the time donation)
- specialty of the intensive care unit (ICU) general surgery (information given at the time donation)
Diseases:
- Malignant neoplasm of ampulla of Vater [C24.1]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Capsule-reactive protein (CRP) |
Qual: positive
Quant: 86.40 mg/L
Source: this donation
|
< 5.00 mg/L
|
Method: Turbidimetry System: cobas 6000 Roche |
| Procalcitonin (PCT) |
Qual: negative
Quant: 0.10 ng/mL
Source: this donation
|
< 0.50 ng/mL
|
Method: EIA (Enzyme Immuno Assay) System: cobas Roche |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH281451
1.2 mL (€60.00)
Human Serum - C50.8
- Donor:
- Gender: Female Age: 55
- Diagnosed disease:
- C50.8 - Malignant neoplasm of overlapping lesion of breast
- Parameter:
- Anti-Glutamate Decarboxylase (GAD) Anti-Protein Tyrosine Phosphatase-like Protein IA-2 Antibodies (IA-2)
Donor:
- Gender:
- Female
- Age:
- 55 Years
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of overlapping lesion of breast [C50.8]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Glutamate Decarboxylase (GAD) |
Qual: negative
Quant: < 5.00 IU/mL
Source: this donation
|
< 10.00 IU/mL
|
Method: EIA (Enzyme Immuno Assay) System: Euroimmun Analyzer EUROIMMUN AG |
| Anti-Protein Tyrosine Phosphatase-like Protein IA-2 Antibodies (IA-2) |
Qual: negative
Quant: < 10.00 IU/mL
Source: this donation
|
< 10.00 IU/mL
|
Method: EIA (Enzyme Immuno Assay) System: not specified not specified |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH240780
0.9 mL (€22.50)
Human Serum - Thyroxine (FT4), Triiodothyronine (FT3) - C64
- Donor:
- Gender: Male Age: 40
- Diagnosed disease:
- C64
- Parameter:
- Thyroxine (FT4) Triiodothyronine (FT3)
Donor:
- Gender:
- Male
- Age:
- 40 Years
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- kidney carcinoma [C64]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Thyroxine (FT4) |
Qual:
Quant: 48.77 ng/L
Source: this donation
|
9,3 - 17,0 (adults) ng/L
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: cobas 8000 Roche |
| Triiodothyronine (FT3) |
Qual:
Quant: 12.03 pg/ml
Source: this donation
|
2,00 - 4,40 (adults) pg/ml
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: cobas 8000 Roche |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH281725
1.1 mL (€41.25)
Human Serum - C68.0
- Donor:
- Gender: Female Age: 87
- Diagnosed disease:
- C68.0 - Malignant neoplasm of urethra
- Parameter:
- Anti-Glutamate Decarboxylase (GAD) Anti-Protein Tyrosine Phosphatase-like Protein IA-2 Antibodies (IA-2)
Donor:
- Gender:
- Female
- Age:
- 87 Years
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of urethra [C68.0]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Glutamate Decarboxylase (GAD) |
Qual: negative
Quant: < 5.00 IU/mL
Source: this donation
|
< 10.00 IU/mL
|
Method: EIA (Enzyme Immuno Assay) System: Euroimmun Analyzer EUROIMMUN AG |
| Anti-Protein Tyrosine Phosphatase-like Protein IA-2 Antibodies (IA-2) |
Qual: negative
Quant: < 10.00 IU/mL
Source: this donation
|
< 10.00 IU/mL
|
Method: EIA (Enzyme Immuno Assay) System: not specified not specified |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH177392
1 mL (€50.00)
Human Serum - Thyroxine (FT4), Triiodothyronine (FT3) - C64
- Donor:
- Gender: Male Age: 40
- Diagnosed disease:
- C64
- Parameter:
- Thyroxine (FT4) Triiodothyronine (FT3)
Donor:
- Gender:
- Male
- Age:
- 40 Years
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- kidney carcinoma [C64]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Thyroxine (FT4) |
Qual:
Quant: 35.85 ng/L
Source: this donation
|
9,3 - 17,0 (adults) ng/L
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: cobas 8000 Roche |
| Triiodothyronine (FT3) |
Qual:
Quant: 9.45 pg/ml
Source: this donation
|
2,00 - 4,40 (adults) pg/ml
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: cobas 8000 Roche |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH281761
1.6 mL (€60.00)
Human EDTA plasma - Neuron-specific enolase (NSE) - C80.9
- Donor:
- Gender: Male Age: 72
- Diagnosed disease:
- D35.0 - Benign neoplasm of adrenal gland
- Parameter:
- Neuron-specific enolase (NSE)
Donor:
- Gender:
- Male
- Age:
- 72 Years
Sample:
- Matrix:
- EDTA plasma
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm, primary site unspecified [C80.9]
- Benign neoplasm of adrenal gland [D35.0]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Neuron-specific enolase (NSE) |
Qual: positive
Quant: 28.90 µg/L
Source: this donation
|
< 15.00 µg/L
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: cobas Roche |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH239680
1 mL (€75.00)
Human Serum - Cancer-Antigen 19-9 (CA 19-9) - C80.0
- Donor:
- Gender: Female Age: 68
- Diagnosed disease:
- C80.0 - Malignant neoplasm, primary site unknown, so stated
- Parameter:
- Cancer-Antigen 19-9 (CA 19-9)
Donor:
- Gender:
- Female
- Age:
- 68 Years
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Preanalytics:
- Details:
- centrifugation (10 min, 2500 x g = 3255 rpm, 20°C)
Diseases:
- Malignant neoplasm, primary site unknown, so stated [C80.0]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Cancer-Antigen 19-9 (CA 19-9) |
Qual: positive
Quant: 222.10 U/mL
Source: this donation
|
< 39 U/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: cobas Roche |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH194699
0.4 mL (€65.00)
Human Serum - Alpha-1-Fetoprotein (AFP) - D35.2
- Donor:
- Gender: Male Age: 79
- Diagnosed disease:
- D35.2 - Benign neoplasm of pituitary gland
- Parameter:
- Alpha-1-Fetoprotein (AFP)
Donor:
- Gender:
- Male
- Age:
- 79 Years
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Preanalytics:
- Details:
- centrifugation (10 min, 2500 x g = 3255 rpm, 20°C)
Diseases:
- Benign neoplasm of pituitary gland [D35.2]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Alpha-1-Fetoprotein (AFP) |
Qual: positive
Quant: 11.70 ng/mL
Source: this donation
|
< 10 ng/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: cobas Roche |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH275681
0.4 mL (€65.00)
Human Serum - Cancer-Antigen 19-9 (CA 19-9) - D37.70
- Donor:
- Gender: Female Age: 85
- Diagnosed disease:
- D37.70
- Parameter:
- Cancer-Antigen 19-9 (CA 19-9)
Donor:
- Gender:
- Female
- Age:
- 85 Years
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Preanalytics:
- Details:
- centrifugation (10 min, 2500 x g = 3255 rpm, 20°C)
Diseases:
- D37.70
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Cancer-Antigen 19-9 (CA 19-9) |
Qual: positive
Quant: 84.00 U/mL
Source: this donation
|
< 39 U/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: cobas Roche |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH167100
0.5 mL (€81.25)
Human Serum - C44.6
- Donor:
- Gender: Male Age: 64
- Diagnosed disease:
- C44.6 - Malignant neoplasm of skin of upper limb, including shoulder
- Parameter:
- Protein S-100
Donor:
- Gender:
- Male
- Age:
- 64 Years
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Preanalytics:
- Details:
- centrifugation (10 min, 2500 x g = 3255 rpm, 20°C)
Diseases:
- Malignant neoplasm of skin of upper limb, including shoulder [C44.6]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Protein S-100 |
Qual: negative
Quant: 0.03 µg/L
Source: this donation
|
< 0.11 µg/L
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: cobas Roche |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH78657
0.5 mL (€81.25)
Human Serum - C67.8
- Donor:
- Gender: Male Age: 74
- Diagnosed disease:
- C67.8 - Malignant neoplasm of overlapping lesion of bladder
- Parameter:
- Prostate specific antigen (PSA), total
Donor:
- Gender:
- Male
- Age:
- 74 Years
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Preanalytics:
- Details:
- centrifugation (10 min, 2500 x g = 3255 rpm, 20°C)
Diseases:
- Malignant neoplasm of overlapping lesion of bladder [C67.8]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Prostate specific antigen (PSA), total |
Qual: negative
Quant: 0.34 ng/mL
Source: this donation
|
< 4.4 ng/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: cobas Roche |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH167273
0.5 mL (€81.25)
Human Serum - D48.0
- Donor:
- Gender: Male Age: 36
- Diagnosed disease:
- D48.0 - Neoplasm of uncertain or unknown behaviour of bone and articular cartilage
- Parameter:
- Alpha-1-Fetoprotein (AFP)
Donor:
- Gender:
- Male
- Age:
- 36 Years
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Preanalytics:
- Details:
- centrifugation (10 min, 2500 x g = 3255 rpm, 20°C)
Diseases:
- Neoplasm of uncertain or unknown behaviour of bone and articular cartilage [D48.0]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Alpha-1-Fetoprotein (AFP) |
Qual: negative
Quant: 2.20 ng/mL
Source: this donation
|
< 10 ng/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: cobas Roche |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH275564
0.5 mL (€81.25)
Human Serum - Lactate dehydrogenase (LDH) - C67.8
- Donor:
- Gender: Female Age: 53
- Diagnosed disease:
- C67.8 - Malignant neoplasm of overlapping lesion of bladder
- Parameter:
- Lactate dehydrogenase (LDH)
Donor:
- Gender:
- Female
- Age:
- 53 Years
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Preanalytics:
- Details:
- centrifugation (10 min, 2500 x g = 3255 rpm, 20°C)
Diseases:
- Malignant neoplasm of overlapping lesion of bladder [C67.8]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Lactate dehydrogenase (LDH) |
Qual: positive
Quant: 5.37 µmol/s/L
Source: this donation
|
< 4.16 µmol/s/L
|
Method: Photometry System: cobas Roche |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH167207
0.5 mL (€81.25)
Human Serum - Prostate specific antigen (PSA), total - C67.8
- Donor:
- Gender: Male Age: 77
- Diagnosed disease:
- C67.8 - Malignant neoplasm of overlapping lesion of bladder
- Parameter:
- Prostate specific antigen (PSA), total
Donor:
- Gender:
- Male
- Age:
- 77 Years
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Preanalytics:
- Details:
- centrifugation (10 min, 2500 x g = 3255 rpm, 20°C)
Diseases:
- Malignant neoplasm of overlapping lesion of bladder [C67.8]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Prostate specific antigen (PSA), total |
Qual: positive
Quant: 10.83 ng/mL
Source: this donation
|
< 4.4 ng/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: cobas Roche |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH275646
0.5 mL (€81.25)
Human Serum - C62.1
- Donor:
- Gender: Male Age: 16
- Diagnosed disease:
- C62.1 - Malignant neoplasm of descended testis
- Parameter:
- Alpha-1-Fetoprotein (AFP)
Donor:
- Gender:
- Male
- Age:
- 16 Years
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Preanalytics:
- Details:
- centrifugation (10 min, 2500 x g = 3255 rpm, 20°C)
Diseases:
- Malignant neoplasm of descended testis [C62.1]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Alpha-1-Fetoprotein (AFP) |
Qual: negative
Quant: 0.80 ng/mL
Source: this donation
|
< 10 ng/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: cobas Roche |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH167364
0.5 mL (€81.25)
Human Serum - Cancer-Antigen 125 (CA 125) - C80.0
- Donor:
- Gender: Female Age: 68
- Diagnosed disease:
- C80.0 - Malignant neoplasm, primary site unknown, so stated
- Parameter:
- Cancer-Antigen 125 (CA 125)
Donor:
- Gender:
- Female
- Age:
- 68 Years
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Preanalytics:
- Details:
- centrifugation (10 min, 2500 x g = 3255 rpm, 20°C)
Diseases:
- Malignant neoplasm, primary site unknown, so stated [C80.0]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Cancer-Antigen 125 (CA 125) |
Qual: positive
Quant: 121.70 U/mL
Source: this donation
|
< 35 U/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: cobas Roche |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH194708
0.5 mL (€81.25)
Human Serum - Cancer-Antigen 125 (CA 125) - C80.0
- Donor:
- Gender: Female Age: 68
- Diagnosed disease:
- C80.0 - Malignant neoplasm, primary site unknown, so stated
- Parameter:
- Cancer-Antigen 125 (CA 125)
Donor:
- Gender:
- Female
- Age:
- 68 Years
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Preanalytics:
- Details:
- centrifugation (10 min, 2500 x g = 3255 rpm, 20°C)
Diseases:
- Malignant neoplasm, primary site unknown, so stated [C80.0]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Cancer-Antigen 125 (CA 125) |
Qual: positive
Quant: 43.60 U/mL
Source: this donation
|
< 35 U/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: cobas Roche |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH194710
0.5 mL (€81.25)
